Scinai Immunotherapeutics (SCNI) Share-based Compensation (2016 - 2023)

Scinai Immunotherapeutics' (SCNI) quarterly Share-based Compensation came in at $252000.0 in Q1 2023, down 48.04% year-on-year from $485000.0 in Q1 2022, and down 48.04% quarter-over-quarter from $485000.0 in Q1 2022.

Scinai Immunotherapeutics (SCNI) Share-based Compensation (2016 - 2023) Analysis & Trends

Scinai Immunotherapeutics has disclosed Share-based Compensation across 4 years of filings, most recently posting $252000.0 for Q1 2023.

  • Share-based Compensation for Q1 2023 came in at $252000.0, down 48.04% year-over-year; the trailing twelve-month figure through Sep 2017 was $3.4 million (changed N/A YoY), and the FY2025 annual result was $303000.0, down 55.57% from the prior year.
  • Share-based Compensation came in at $252000.0 for Q1 2023 at Scinai Immunotherapeutics, down from $485000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $485000.0 in Q1 2022 to a low of $252000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Scinai Immunotherapeutics 3.02 Bn 988.23 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 252,000.00
Mar 31, 2023 252,000.00
Mar 31, 2022 485,000.00
Mar 31, 2022 485,000.00
Sep 30, 2017 3.35 Mn
Sep 30, 2017 3.35 Mn
Jun 30, 2017 5.22 Mn
Jun 30, 2017 5.22 Mn
Mar 31, 2017 2.99 Mn
Mar 31, 2017 2.99 Mn
Jun 30, 2016 1.28 Mn
Jun 30, 2016 1.28 Mn
Mar 31, 2016 1.21 Mn
Mar 31, 2016 1.21 Mn